Publication

Charaiveti is more than just a memoir—it is a sharp-eyed look at where we have been and where we may be headed, as seen through the lens of a remarkable life. …

OCALA, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of results from the Phase 1 study at Roswell …

KT-474 showed evidence of robust target degradation and pathway inhibition with a favorable safety profile in healthy volunteers and patients Trial showed encouraging impact on disease burden and symptoms in …

Releasing in January 2024 NEW DELHI , Nov. 9, 2023 /PRNewswire/ — A legend in the arena of wildlife conservation and affectionately hailed as the ‘Snakeman of India’, Romulus Whitaker has …

EINDHOVEN, the Netherlands, Nov. 06, 2023 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence …

Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides rationale for development in a range of additional Th2- and Th17-mediated diseases Soquelitinib’s unique mechanism of action inhibited …